GENEREX BIOTECHNOLOGY CORP

FREE EMAIL WATCHDOG

Get free email notifications about news in GENEREX BIOTECHNOLOGY CORP.

The service is free and you can unsubscribe at any time.

General | People (83) | Filings (692) | Investment rounds (2) | Annual reports (5) | Stock | News

Industry: PHARMACEUTICAL PREPARATIONS [2834]

CIK Number: 0001059784
IRS Number: 820490211

GENEREX BIOTECHNOLOGY CORP is a publicly traded company

Trading symbol: GNBT

GENEREX BIOTECHNOLOGY CORP is on the market more than 5 years.

News

2017-08-20

Is There Strength Behind the Numbers For Generex Biotechnology Corporation ...
Clayton News
Generex Biotechnology Corporation (OTCPK:GNBT) has a Price to Book ratio of -0.069358. This ratio has been calculated by dividing the current share price by the book value per share.

2017-08-19

Generex Biotechnology Corp (GNBT) Price Below The Cloud: Shows Negative Momentum
Rockville Register
Shares of Generex Biotechnology Corp (GNBT) recently touched 4.2400, which places the stock below the Ichimoku cloud, indicating bearish momentum and a potential sell signal for the equity.

2017-08-17

Generex Biotechnology Corp (GNBT) Chaikin Money Flow Climbs Above Zero
Hayden Business Journal
Generex Biotechnology Corp (GNBT) shares have moved above the Chalkin Money Flow zero line, indicating potential buying momentum for the shares.

2017-08-14

Generex Biotechnology Corp (GNBT) Charts Showing Bullish Optimism
Davidson Register
Shares of Generex Biotechnology Corp (GNBT) are on watch as the Tenkan Line has moved above the Kijun line, indicating positive momentum for the equity.

2017-08-11

Generex Biotechnology Corp (GNBT) RMI Climbing Towards Key Levels
Stock Daily Review
Shares of Generex Biotechnology Corp (GNBT) have seen the Relative Momentum Indicator (RMI) climb higher over the past 5 sessions.

2017-08-07

Generex Provides Summary of Ii-Key Hybrid Vaccine Platform
Business Wire (press release)
MIRAMAR, Fla.--(BUSINESS WIRE)--Generex Biotechnology Corporation (www.generex.com) (OTCPink:GNBT) today provided the following summary of the Ii-Key Hybrid Vaccine Platform under development by its wholly-owned subsidiary, Antigen Express, ...

2017-08-07

Is a Near-Term Bullish Trend Developing for Generex Biotechnology Corp (GNBT)?
Lenox Ledger
Generex Biotechnology Corp (GNBT) shares are being placed on chartists radar as the recent share price of 3.9500 is holding above the balance step moving average.

GENEREX BIOTECHNOLOGY CORP address

10102 USA TODAY WAY
MIRAMAR
33025

Company jurisdiction

DELAWARE

Entity type

Corporation

Earliest known filing

December 1998

Latest known filing

August 2017

Company filings

SEC filings are a great source of information for companies including investments, company events, and all sorts of other information.

GENEREX BIOTECHNOLOGY CORP has 692 filings. View GENEREX BIOTECHNOLOGY CORP filings.

Annual Reports

Quarterly Reports

Latest company events

Investment Rounds

GENEREX BIOTECHNOLOGY CORP recieved 2 investments.

People

We have found 83 people related to GENEREX BIOTECHNOLOGY CORP.